申请人:Heinrich-Pette-Institut
公开号:EP1834669A1
公开(公告)日:2007-09-19
The present invention relates to the use of specific hydrazone compounds for the treatment of viral infections, in particular of retroviral infections and most preferably of lentiviral or oncoretroviral infections. According to a specific embodiment of the invention, the compound is 2-[4-(aminoiminomethyl)-2,3-dihydro-1H-inden-1-ylidene]-hydrazinecarboximidamide or a salt thereof, and the retroviral infection is an HIV infection, in particular HIV-1.
本发明涉及使用特定的腙化合物治疗病毒感染,特别是逆转录病毒感染,最优选的是慢病毒或逆转录病毒感染。根据本发明的一个具体实施例,该化合物是 2-[4-(氨基亚氨基甲基)-2,3-二氢-1H-茚-1-亚基]-肼甲脒或其盐,逆转录病毒感染是 HIV 感染,特别是 HIV-1。